Phenotype-guided approach for device-based therapies in heart failure.

Abstract excerpt

Device-based therapies have become integral in the management of heart failure (HF). By targeting structural or neurohormonal pathways, these therapies provide additional benefits beyond those provided by pharmacologic therapies or correct structural abnormalities that may not be amenable to drug therapy. However, a comprehensive framework for device selection tailored to individual clinical profiles and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Defibrillators, Implantable
• Share to Heart Failure